'Minimally invasive'. Training at ‘Focus: Valve’ Innsbruck (10-13 September)

Focus Valve 2017
'Focus: Valve'

Medical University Innsbruck (Austria) is organising the 9th ‘Focus: Valve’ meeting, September 10 through 13. ‘Focus: Valve’ closely follows current medical technical developments and the training needs that they create among clinicians. The organisation describes its vision as follows: 

“The increasing importance of interventional techniques is stimulating the development of less invasive surgical procedures as well as the incorporation of transcatheter techniques into the surgical portfolio. FOCUS Valve 2017 will therefore be dedicated to the newest developments and techniques in minimally invasive surgical and interventional treatment of heart valve disease.”

FOCUS Valve is not like a regular meeting or conference since it is dedicated to one thing: training. The training sessions in the wet lab, which will take place on September 13, are facilitated by LifeTec Group.


The training programme offers two procedures:

Transcatheter Aortic Valve Implantation (TAVI)


Transcatheter Mitral Valve Repair (MitraClip®)

For those outside the medical profession, allow us to explain that both procedures are of the so-called ‘minimally invasive’ kind. This means they’re much easier to take for cardiac patients than ‘old-fashioned’ open heart surgery, for example. What the two procedures to be trained on September 13 have in common is that they both reach the heart and the ‘faulty’ valve through a catheter, via an artery or an incision in the chest. So there is no need to open up the chest. An important difference between the two procedures is that one deals with the ‘aorta valve’ and the other with the ‘mitral valve’. 

LifeTec Group Tech & Training

LifeTec Group began training heart surgeons as a consequence of its Preclinical Contract Research activities.

With the Contract Research activities, LifeTec Group helps medtech companies, the academic world and the clinical world to develop their own ideas and turn them into solutions for patients. Combining the expertise of the idea owner with the wealth of knowledge and experience that LifeTec Group has to offer in the field of biomedical technology, the company sets up projects in which research platforms play an important role. 

The research platforms developed by LifeTec Group are so ‘close to real’ that they save a lot of time, which also means money, and a lot of test animals to boot. 

It is precisely these research platforms, and their 'close to real' properties, that offer opportunities not only for research but also for the training of cardiac surgeons, among others. These surgeons train on real hearts in which blood circulation is simulated by means of a circulation system, with realistic blood pressure values. During the procedure, the surgeons are informed by the same visual aids as used in the OR.


‘Focus: Valve’ is partly made possible by a number of big and renowned medtech companies, among them Edwards, B. Braun, Abbott, Philips and Medtronic. And last but not least: by LifeTec Group’s Sjoerd van Tuijl and Marco Stijnen.

Head of MedTech Innovation

Marco Stijnen

Senior Research Engineer

Sjoerd van Tuijl

Relevant links and background:


Trained procedures:


Course location:

Medical University Innsbruck

Chirurgie (Building no. 8),

Grosser Hörsaal,

6020 Innsbruck, Austria


Congress contact:

Medical University Innsbruck

Department of Cardiac Surgery

Anichstrasse 35, 6020 Innsbruck, Austria

Gabriele Wagner

Phone: +43 512 504–22349

Email: gabriele.wagner@tirol-kliniken.at


©2021 LifeTec Group.  Legal  Credits